Stockreport

IGC Reports Financial Results for Fiscal Year Ended March 31, 2024

IGC Pharma, Inc.  (IGC) 
NASDAQ:AMEX Investor Relations: igcinc.us/investor-center/overview
PDF POTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC), a clinical-stage pharmaceutical company, has announced its financial r [Read more]